76336-00-0 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 4-hydroxy-7-methyl-2-oxo-1-propyl-1,2-dihydro-1,8-naphthyridine-3-carboxylate is used as a potential pharmaceutical agent for its possible biological activity and pharmacological properties. The presence of the naphthyridine ring and additional functional groups may contribute to its efficacy in treating certain medical conditions, although further research is required to determine its specific applications and mechanisms of action.
Used in Agrochemical Industry:
In the agrochemical sector, ethyl 4-hydroxy-7-methyl-2-oxo-1-propyl-1,2-dihydro-1,8-naphthyridine-3-carboxylate may be utilized as a component in the development of new pesticides or herbicides. Its unique structure and functional groups could potentially offer novel modes of action or enhanced selectivity for controlling pests or unwanted plant growth, subject to further investigation and development.
Used in Industrial Processes:
Ethyl 4-hydroxy-7-methyl-2-oxo-1-propyl-1,2-dihydro-1,8-naphthyridine-3-carboxylate could also find applications in various industrial processes, such as in the synthesis of other complex organic compounds or as an intermediate in the production of specialty chemicals. Its unique structure and functional groups may provide advantages in specific chemical reactions or product formulations, pending further exploration and testing.
Check Digit Verification of cas no
The CAS Registry Mumber 76336-00-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,6,3,3 and 6 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 76336-00:
(7*7)+(6*6)+(5*3)+(4*3)+(3*6)+(2*0)+(1*0)=130
130 % 10 = 0
So 76336-00-0 is a valid CAS Registry Number.
76336-00-0Relevant academic research and scientific papers
Antisecretory 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives
-
, (2008/06/13)
Substituted 4-oxy-3-carboxy or cyano-1,2-dihydro-2-oxo-1,8-naphthyridine derivatives as gastric antisecretory agents for use in the treatment of peptic ulcer disease.
